1. Home
  2. DMLP vs YDES Comparison

DMLP vs YDES Comparison

Compare DMLP & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DMLP
  • YDES
  • Stock Information
  • Founded
  • DMLP 2003
  • YDES 2013
  • Country
  • DMLP United States
  • YDES Taiwan
  • Employees
  • DMLP N/A
  • YDES N/A
  • Industry
  • DMLP Oil & Gas Production
  • YDES
  • Sector
  • DMLP Energy
  • YDES
  • Exchange
  • DMLP Nasdaq
  • YDES Nasdaq
  • Market Cap
  • DMLP 1.1B
  • YDES 1.1B
  • IPO Year
  • DMLP N/A
  • YDES N/A
  • Fundamental
  • Price
  • DMLP $22.88
  • YDES $8.75
  • Analyst Decision
  • DMLP
  • YDES
  • Analyst Count
  • DMLP 0
  • YDES 0
  • Target Price
  • DMLP N/A
  • YDES N/A
  • AVG Volume (30 Days)
  • DMLP 145.5K
  • YDES 67.2K
  • Earning Date
  • DMLP 11-06-2025
  • YDES 09-30-2025
  • Dividend Yield
  • DMLP 14.06%
  • YDES N/A
  • EPS Growth
  • DMLP N/A
  • YDES N/A
  • EPS
  • DMLP 1.13
  • YDES N/A
  • Revenue
  • DMLP $143,803,000.00
  • YDES $510,360.00
  • Revenue This Year
  • DMLP N/A
  • YDES N/A
  • Revenue Next Year
  • DMLP N/A
  • YDES N/A
  • P/E Ratio
  • DMLP $20.16
  • YDES N/A
  • Revenue Growth
  • DMLP N/A
  • YDES 45.76
  • 52 Week Low
  • DMLP $22.56
  • YDES $5.30
  • 52 Week High
  • DMLP $34.88
  • YDES $25.00
  • Technical
  • Relative Strength Index (RSI)
  • DMLP 34.80
  • YDES N/A
  • Support Level
  • DMLP $22.55
  • YDES N/A
  • Resistance Level
  • DMLP $23.87
  • YDES N/A
  • Average True Range (ATR)
  • DMLP 0.60
  • YDES 0.00
  • MACD
  • DMLP -0.18
  • YDES 0.00
  • Stochastic Oscillator
  • DMLP 13.19
  • YDES 0.00

About DMLP Dorchester Minerals L.P. Common Units Representing Limited Partnership Interests

Dorchester Minerals LP operates as the owner of producing and non-producing crude oil and natural gas mineral, royalty, overriding royalty, net profits and leasehold interests. The company generates revenues from royalties, net profits interests, lease bonus, and others. It has leasehold interests in approximately 592 counties and parishes in around 28 states.

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Share on Social Networks: